Cancers affecting the gastrointestinal tract can sometimes spread to the peritoneum, leading to advanced disease. In such cases, conventional treatments may not be sufficient. This is where CRS HIPEC has emerged as a revolutionary option in gastrointestinal cancer treatment.
Dr. Ninad Katdare, a leading cancer surgeon in Mumbai, specializes in performing this complex yet highly effective procedure. CRS HIPEC combines two critical steps, removal of visible tumors and targeted chemotherapy, to improve survival and quality of life.
The first step, cytoreductive surgery, involves carefully removing all visible cancer deposits from the abdominal cavity. This can be a lengthy procedure, requiring high surgical expertise. Once this is completed, heated chemotherapy is circulated within the abdomen to eliminate residual microscopic cancer cells.
This approach is particularly beneficial for patients with peritoneal cancer, which often arises from colorectal or gastric cancers. It has also shown promising results in selected cases of ovarian cancer treatment, where the disease has spread within the abdomen.
For patients who are not candidates for CRS HIPEC, PIPAC cancer treatment offers a less invasive alternative. It allows repeated administration of chemotherapy with minimal recovery time, making it suitable for patients with advanced disease or reduced fitness for surgery.
The role of a skilled cancer surgeon in Mumbai is crucial in determining the right treatment plan. Each patient requires a personalized approach based on the extent of disease, overall health, and treatment goals.
With continuous advancements in oncology, treatments like CRS HIPEC are redefining the management of advanced abdominal cancers. Patients now have access to therapies that not only extend survival but also improve quality of life.
